Theresa May, the British Prime Minister, will call on the health service, charities and artificial intelligence sector of the United Kingdom to work together to better distinguish patients that are in the early stages of cancer and stop the thousands of people that are dying every year.
May is struggling to unite her top ministers over plans to withdraw from the European Union. She aims to broaden her agenda as an attempt to show that she is more than a leader who is just overseeing the Brexit discussions, which have all but postponed over customs arrangements.
In a speech that she is scheduled to make in northern England on Monday, May will reveal plans which she says should see at least 50,000 people every year that are diagnosed at an early stage of ovarian, prostate, bowel, or lung cancer – people who would have been diagnosed otherwise at a later and more deadly stage.
According to the excerpts of her speech, she will say: “Late diagnosis of otherwise treatable illnesses is one of the biggest causes of avoidable deaths.
“And the development of smart technologies to analyse great quantities of data quickly and with a higher degree of accuracy than is possible by human beings opens up a whole new field of medical research and gives us a new weapon in our armoury in the fight against disease.”
She will say that with the use of the data on the habits, medical records, and genetics of people, doctors would then be able to make referrals to an oncologist earlier.
She will also say that the innovation on health is part of the industrial strategy of her government, part of measures to make sure that the United Kingdom is at the forefront of the development of new technology as it withdraws from the European Union.
The chief executive of Cancer Research, Harpel Kumar, said that the United Kingdom “must remain an attractive place for the life sciences industry to invest,” something that some worry is under threat due to Brexit.
He said: “If this platform unites government, academia, the charity sector, and industry, we will be primed to accelerate innovation and lead the healthcare sector to new heights.”